Started with its first stapler used in China in 2013, Fengh has since then been witnessed a rapid growth, not only in sales in a continuously increasing number of countries on every continent, but also in such new value-added endeavors as technical innovation and procedure development.Fengh has consistently invested a double-digit percentage of its annual revenue in technical innovations over the past 6 years. Now with a couple of dozen patents granted and more than 200 innovations filed, Fengh has successfully emerged as a leading innovation-driven enterprise in China, committed to researching, developing, manufacturing and marketing products for minimally invasive and laparoscopic surgery proocedures.

Rooted in China, the biggest developing economy with a significantly large portion of its population aging and/or in poverty, Fengh understands how important it is to offer healthcare professionals and ultimately patients, the products and solutions well balanced with good quality and more affordable price. To that end, Fengh has been taking tremendous effort to consolidate its supply chain in different countries, streamline its state-of-the-art manufacturing facilities and enhance its quality management systems in Wu Xi, Su Zhou and Shanghai, the most advanced areas in China.

Fengh Medical safeguards a level playing field in the surgical stapling landscape while forcefully competing on merits. Our focus on quality, continued investment in innovation and commitment on improving patient care are the core values of our organization. This mission statement allows us to grow in an extremely concentrated market.Today, tens of thousands of healthcare professionals and patients around the world are benefiting from Fengh’s products, which they are happy with and are proud of. Focus on quality, invest in innovations and care about patients! With Fengh, we grow together.